Pharmaceuticals

Global Anti-Inflammatory Therapeutics Market Landscape: Trends and Market Share to 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Will the Anti-Inflammatory Therapeutics Market Evolve in Terms of Growth and Size by 2029?#_x000D_

In recent years, we’ve seen a gradual increase in the hypolipidemics market size. It is projected to escalate from $30.72 billion in 2024 to $31.91 billion in 2025, with a compound annual growth rate (CAGR) of 3.9%. During the study period, the primary growth drivers were a rising incidence of hyperlipidemia, lifestyle modifications, ageing demographics, enhanced awareness and screening, and the commanding presence of statins._x000D_

_x000D_

In the subsequent years, the hypolipidemics market size is anticipated to experience consistent growth, and it is forecasted to expand to $35.99 billion in 2029 at a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this growth during the forecast period include personalized medicine, an enlarging patient pool, emerging markets, governmental initiatives, and combination therapies. Noteworthy trends expected within the forecast period include a shift from LDL to non-HDL cholesterol management, the rise of digital health and telemedicine, market consolidation and competition, and patient-focused approaches._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2435&type=smp_x000D_

_x000D_

#What factors are expected to fuel Anti-Inflammatory Therapeutics market growth in the coming years?#_x000D_

The growth of the anti-inflammatory therapeutics market is predicted to be fueled by the rising prevalence of inflammatory bowel disease. Characterized by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) is a persistent health condition. In the management of Crohn’s disease, anti-inflammatory therapeutics are significant as they mitigate inflammation, control disease symptoms, and lower the likelihood of surgical intervention. A July 2023 report from the Oxford University Press (OUP), the publication body of the University of Oxford, recorded IBD incidence at 10.9 per 100,000 person-years and prevalence at 721 per 100,000 individuals. Therefore, this rise in inflammatory bowel disease prevalence is triggering the expansion of the anti-inflammatory therapeutics market._x000D_

_x000D_

The hypolipidemics market covered in this report is segmented – _x000D_

_x000D_

1) By Product Type: Cholic Acid Regulator, HMG-CoA Reductase Inhibitors, Adenylate Cyclase Inhibitors, Nicotinic Acid Drugs, Other Types_x000D_

2) By Drug Type: Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, Other Drug Types_x000D_

3) By Application: Hospital, Clinics, Pharmacy, Cardiovasology_x000D_

_x000D_

Subsegments:_x000D_

1) By Cholic Acid Regulator: Bile Acid Sequestrants, Fibrates _x000D_

2) By HMG-CoA Reductase Inhibitors: Atorvastatin, Rosuvastatin, Simvastatin, Lovastatin, Pravastatin, Fluvastatin _x000D_

3) By Adenylate Cyclase Inhibitors: Cilostazol, Milrinone _x000D_

4) By Nicotinic Acid Drugs: Niacin (Vitamin B3), Extended-release Niacin _x000D_

5) By Other Types: Omega-3 Fatty Acid Derivatives, PCSK9 Inhibitors, Ezetimibe, Bempedoic Acid_x000D_

_x000D_

#Which Trends Are Redefining The Future Landscape Of The Anti-Inflammatory Therapeutics Industry?#_x000D_

Businesses within this market have started to invest more significantly in employing data from wearable technologies to enhance the pace and performance of clinical trials, subsequently lowering overall expenses. The continuous collection of patient data using wearable technologies might alleviate the need for frequent site visits, potentially improving patient retention rates and overall clinical trial efficiencies. Wearable devices address the issue of recruiting patients, monitoring them, providing precise, real-time data, and enabling quicker decision-making while a clinical trial is in progress. Pfizer and Sanofi are examples of pharmaceutical corporations that have made investments in wearable technology to treat hypolipidemia._x000D_

_x000D_

#What Are The Most Active Companies In The Anti-Inflammatory Therapeutics Market Today?#_x000D_

Major companies operating in the hypolipidemics market include Abbott Laboratories Limited, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited, Chunghwa Chem Syn& Biotech Co. Ltd., Concord Biotech Limited, Croda Europe Limited, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd., DSM Sinochem Pharma India Pvt. Ltd., Hikal Chemicals Industries Limited, Ipca Laboratories Ltd., Lek Pharmaceuticals D.d, Lupin Limited, Merck Sharp & Dohme B.V, Mylan N.V, Nexchem Pharmaceutical Co. Ltd., Olon S.p.A, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Zhejiang Jiangbei Pharma Co. Ltd., Moehs Iberica S.L. ES, Pfizer Inc., Recordati S.p.A., AstraZeneca Plc, Amgen Plc, Daiichi Sankyo Company Limited, Kowa Company Ltd., Sanofi-Aventis, Novartis AG, Viatris Inc., Pfizer Inc., GlaxoSmithKline plc, Cipla Limited, Torrent Pharmaceuticals Ltd., Zydus Lifesciences Limited, Wockhardt Limited, Alembic Pharmaceuticals Limited, Jubilant Life Sciences Limited, Hetero Drugs Limited, Ind-Swift Laboratories Ltd., Intas Pharmaceuticals Ltd., Unichem Laboratories Ltd._x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report_x000D_

_x000D_

#Which Regional Markets Are Attracting The Most Investment In Anti-Inflammatory Therapeutics?#_x000D_

North America was the largest region in the hypolipidemic drugs market in 2024. The Middle East is expected to be the fastest-growing region in the hypolipidemic drugs market during the forecast period. The regions covered in the hypolipidemics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2435&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_